Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Expression of genes related to apoptosis, cell cycle and signaling pathways are independent of TP53 status in urinary bladder cancer cells (2011)

  • Authors:
  • USP affiliated authors: HOJO, ELZA TIEMI SAKAMOTO - FFCLRP ; PASSOS JUNIOR, GERALDO ALEIXO DA SILVA - FORP
  • USP Schools: FFCLRP; FORP
  • DOI: 10.1007/s11033-010-0536-x
  • Subjects: EXPRESSÃO GÊNICA; NEOPLASIAS DA BEXIGA
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s11033-010-0536-x (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    Informações sobre o Citescore
  • Título: Molecular Biology Reports

    ISSN: 0301-4851

    Citescore - 2017: 1.8

    SJR - 2017: 0.721

    SNIP - 2017: 0.689


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FCLRP2268379pcd 2268379 estantes deslizantes
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SILVA, Glenda Nicioli da; EVANGELISTA, Adriane Feijó; MAGALHÃES, Daniele A.; et al. Expression of genes related to apoptosis, cell cycle and signaling pathways are independent of TP53 status in urinary bladder cancer cells. Molecular Biology Reports, Dordrecht, v. 38, n. 6, p. 4159-4170, 2011. Disponível em: < http://dx.doi.org/10.1007/s11033-010-0536-x > DOI: 10.1007/s11033-010-0536-x.
    • APA

      Silva, G. N. da, Evangelista, A. F., Magalhães, D. A., Macedo, C., Sakamoto-Hojo, E. T., Passos, G. A. S., & Salvadori, D. M. F. (2011). Expression of genes related to apoptosis, cell cycle and signaling pathways are independent of TP53 status in urinary bladder cancer cells. Molecular Biology Reports, 38( 6), 4159-4170. doi:10.1007/s11033-010-0536-x
    • NLM

      Silva GN da, Evangelista AF, Magalhães DA, Macedo C, Sakamoto-Hojo ET, Passos GAS, Salvadori DMF. Expression of genes related to apoptosis, cell cycle and signaling pathways are independent of TP53 status in urinary bladder cancer cells [Internet]. Molecular Biology Reports. 2011 ; 38( 6): 4159-4170.Available from: http://dx.doi.org/10.1007/s11033-010-0536-x
    • Vancouver

      Silva GN da, Evangelista AF, Magalhães DA, Macedo C, Sakamoto-Hojo ET, Passos GAS, Salvadori DMF. Expression of genes related to apoptosis, cell cycle and signaling pathways are independent of TP53 status in urinary bladder cancer cells [Internet]. Molecular Biology Reports. 2011 ; 38( 6): 4159-4170.Available from: http://dx.doi.org/10.1007/s11033-010-0536-x

    Referências citadas na obra
    Kirkali Z, Chan T, Manoharan M, Algaba F, Busch C, Cheng L, Kiemeney L, Kriegmair M, Montironi R, Murphy WM, Sesterhenn IA, Tachibana M, Weider J (2005) Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 66:4–34
    Cookson MS, Herr W, Zhang ZF, Soloway S, Sogani PC, Fair WR (1997) The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol 158:62–67
    Nishiyama H, Habuchi T, Watanabe J, Teramukai S, Tada H, Ono Y, Ohshima S, Fujimoto K, Hirao Y, Fukushima M, Ogawa O (2004) Clinical outcome of a large-scale multi-institutional retrospective study for locally advanced bladder cancer: a survey including 1131 patients treated during 1990–2000 in Japan. Eur Urol 45:176–181
    Cordon-Cardo C (2008) Molecular alterations associated with bladder cancer initiation and progression. Scand J Urol Nephrol Suppl 218:154–165
    Wolff EM, Liang G, Jones PA (2005) Mechanisms of disease: genetic and epigenetic alterations that drive bladder cancer. Nat Clin Pract Urol 2:502–510
    Levine A (2005) The p53 tumor-suppressor gene. N Engl J Med 1992(326):1350–1352
    Sengupta S, Harris CC (2005) p53: traffic cop at the crossroads of DNA repair and recombination. Nat Rev Mol Cell Biol 6:44–55
    Sanchez-Carbayo M, Socci ND, Charytonowicz E, Lu M, Prystowsky M, Childs G, Cordon-Cardo C (2002) Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes. Cancer Res 62:6973–6980
    Sanchez-Carbayo M, Socci ND, Richstone L, Corton M, Behrendt N, Wulkfuhle J, Bochner B, Petricoin E, Cordon-Cardo C (2007) Genomic and proteomic profiles reveal the association of gelsolin to TP53 status and bladder cancer progression. Am J Pathol 171:1650–1658
    Coppée J-Y (2008) Do DNA microarrays have their future behind them? Microbes Infect 10:1067–1071
    Grant GR, Manduchi E, Stoeckert Jr CJ (2007) Analysis and management of microarray gene expression data. Curr Protoc Mol Biol, Chapter 19: Unit 19.6
    Kraemer K, Schmidt U, Fuessel S, Herr A, Wirth MP, Meye A (2006) Microarray analyses in bladder cancer cells: inhibition of hTERT expression down-regulates EGFR. Int J Cancer 119:1276–1284
    Kikuchi T, Daigo Y, Katagiri T, Tsunoda T, Okada K, Kakiuchi S, Zembutsu H, Furukawa Y, Kawamura M, Kobayashi K, Imai K, Nakamura Y (2003) Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs. Oncogene 22:2192–2205
    Staege M, Banning-Eichenseer U, Weibflog G, Volkmer I, Burdach S, Richter G, Mauz-Korholz C, Foll J, Korholz D (2008) Gene expression profiles of Hodgkin’s lymphoma cell lines with different sensitivity to cytotoxic drugs. Exp Hematol 36:886–896
    Cooper MJ, Haluschak JJ, Johsond D, Schwartz S, Morrison LJ, Lippa M, Hatzivassiliou G, Tan J (1994) p53 mutations in bladder carcinoma cell lines. Oncol Res 6:569–579
    Rieger KM, Little AF, Swart JM, Kastrinakis WV, Fitzgerald JM, Hess DT, Libertino JA, Summerhayes IC (1995) Human bladder carcinoma cell lines as indicators of oncogenic change relevant to urothelial neoplastic progression. Br J Cancer 72:683–690
    da Silva GN, Marcondes JPC, Camargo EA, Passos GAS, Sakamoto-Hojo ET, Salvadori DMF (2010) Cell cycle arrest and apoptosis in TP53 subtypes of bladder carcinoma cell lines treated with cisplatin and gemcitabine. Exp Biol Med 235:814–824
    Hegde P, Qi R, Abernathy K, Gay C, Dharap S, Gaspard R, Hughes JE, Snesrud E, Lee N, Quackenbush J (2000) A concise guide to cDNA microarray analysis. Biotechniques 29: 548–550, 552–544, 556 passim
    Spot software [ http://www.tm4.org/spotfinder.html ]
    Ihaka R, Gentleman R (1996) A language for data analysis and graphics. J Comput Graph Stat 5:299–314
    KTH package [ http://www.biotech.kth.se/molbio/microarray/ ]
    Yang YH, Speed T (2002) Design issues for cDNA microarray experiments. Nat Rev Genet 3:579–588
    MEV software [ http://www.tm4.org/mev.html ]
    S.O.U.R.C.E. [ http://smd-www.stanford.edu/cgi-bin/source/sourceSearch ]
    NCBI [ http://www.ncbi.nlm.nih.gov/ ]
    FATIGO [ http://babelomics.bioinfo.cipf.es/ ]
    Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. PNAS 98:5116–5121
    Gene Network [ http://idv.sinica.edu.tw/hchuang/GeneNetwork1.2Setup.exe ]
    Blaveri E, Simko JP, James JE, Brewer JL, Baehner F, DeVries KS, Koppie T, Pejavar S, Carroll P, Waldman F (2005) Bladder cancer outcome and subtype classification by gene expression. Clin Cancer Research 11:4044–4055
    Kato S (2003) Understanding the function structure and function mutation relationships of p53 tumor suppressor protein by high resolution missense mutation analysis. Proc Natl Acad Sci USA 100:8424–8429
    Brosh R, Rotter V (2009) When mutations gain new powers: news from the mutant p53 field. Nat Rev Cancer 10:701–713
    Prives C, Manfredi JJ (2005) The continuing saga of p53—More sleepless nighs ahead. Mol Cell 19:719–721
    Zhao S, Zhang J, Zhang X, Dong X, Sun X (2008) Arsenic trioxide induces different gene expression profiles of genes related to growth and apoptosis in glioma cells dependent on the p53 status. Mol Biol Rep 35:421–429
    Savopoulos JW, Carter PS, Turconi S, Pettman GR, Karran EH, Gray CW, Ward RV, Jenkins O, Creasy CL (2000) Expression, purification, and functional analysis of the human serine protease HtrA2. Protein Expr Purif 19:227–234
    Muzio M, Stockwell BR, Stennicke HR, Salvesen GS, Dixit VM (1998) An induced proximity model for caspase-8 activation. J Biol Chem 273:2926–2930
    Ding SJ, Li Y, Shao XX, Zhou H, Zeng R, Tang ZY, Xiav QC (2004) Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials. Proteomics 4:982–994
    Hinata N, Shirakawa T, Zhang Z, Matsumoto A, Fujisawa M, Okada H, Kamidono S, Gotoh A (2003) Radiation induces p53-dependent cell apoptosis in bladder câncer cells with wild-type-p53 but not in p53-mutated bladder cancer cells. Urol Res 31:387–396
    Esrig D, Spruck CH 3rd, Nichols PW, Chaiwun B, Steven K, Groshen S, Chen SC, Skinner DG, Jones PA, Cote RJ (1993) p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol 143:1389–1397
    Fujita T, Kobayashi Y, Wada O, Tateishi Y, Kitada L, Yamamoto Y, Takashima H, Murayama A, Yano T, Baba T, Kato S, Kawabe Y-I, Yanagisawa J (2003) Full activation of estrogen receptor—activation function-1 induces proliferation of breast cancer cells. J Biol Chemistry 29:26704–26714
    Hecker C-M, Rabiller M, Haglund K, Bayer P, Dikic I (2006) Specification of SUMO1- and SUMO2-interacting motifs. J Biol Chemistry 281:16117–16127
    Niki T, Galli I, Ariga H, Iguchi-Ariga SMM (2000) MSSP, a protein binding to an origin of replication in the c-myc gene, interacts with a catalytic subunit of DNA polymerase α and stimulates its polymerase activity. FEBS Letters 475:209–212
    Kortmansky J, Shah MA, Kaubisch A (2005) Phase I trial of thecyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with fluorouracil in patients with advanced solid tumors. J Clin Oncol 23:1875–1884
    Hart FU (1996) Molecular chaperones in cellular protein folding. Nature 381:571–579
    Moussa O, Yordy JS, Abol-Enein H, Sinha D, Bissada NK, Haluska PV, Ghoneim MA, Watson DK (2005) Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer. Cancer Res 65:11581–11587
    Macheda ML, Rogers S, Best JD (2005) Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 2202:654–662
    Yang Q, Liu S, Tian Y, Hasan C, Kersey D, Salwen HR, Chlenski A, Perlman EJ, Cohn SL (2004) Methylation-associated silencing of the heat shock protein 47 gene in human neuroblastoma. Cancer Res 64:4531–4538
    Wang L, He G, Zhang P, Wang X, Jiang M, Yu L (2010) Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53. Mol Biol Rep [Epub ahead of print]
    Yuan J, Tang W, Luo K, Chen X, Gu X, Wan B, Yu L (2006) Cloning and characterization of the human gene DERP6, which activates transcriptional activities of p53. Mol Biol Rep 33:151–158
    Soussi T, Wiman KG (2007) Shaping genetic alterations in human cancer: the p53 mutation paradigm. Cancer Cell 12:303–312
    Guerreiro Da Silva IS, Hu YF, Russo IH, Ao X, Salicioni AM, Yang X, Russo J (2000) S100P calciumbinding protein overexpression is associated with immortalization of human breast epithelial cells in vitro and early stages of breast cancer development in vivo. Int J Oncol 16:231–240
    Oegema K, Savoian MS, Matchinson TJ, Field CM (2000) Functional analysis of a human homologue of the Drosophila actin binding protein anillin suggests a role in cytokinesis. J Cell Biol 150:539–551